Medication info
Amaria Tablet (Glimepiride)

Amaria Tablet (Glimepiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
TerraGen Etex Co., Ltd.
Appearance
Green rectangular tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200411065 · Notified 2004.09.30 · Insurance code 698500250

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow whole without chewing with at least 1/2 cup of water. Administer this medicine orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration In patients who have not previously received medication, initiate treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider concomitant use with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the requirement for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, follow the method described under Initial dose. That is, initiate treatment at 1 mg daily and adjust the dose at 1 ~ 2 week intervals. Consider the efficacy and duration of action of the previously administered medicine. 4) Dose monitoring While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia is promptly controlled by immediate intake of sugar. Hypoglycemia may recur after treatment with a sulfonylurea despite successful initial management. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical treatment and follow-up and may sometimes require hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure, and should be used when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal. Initiate insulin at a low dose and increase it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If a patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered concomitantly with metformin, and the risk may increase. Appropriate precautions should be taken.

Ingredients

Manufacturer
TerraGen Etex Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is used to help control blood sugar levels in patients with type 2 diabetes. It plays a supportive role in conjunction with dietary and exercise therapy and can be administered alone. However, if blood sugar control is insufficient with oral hypoglycemic agents, it may be used in combination with insulin. Furthermore, in cases where blood sugar control is difficult with sulfonylureas or monotherapy with metformin, it may also be used together with metformin. Thus, the dosage can be flexibly adjusted based on the patient's blood sugar control status to expect optimal therapeutic effects. Overall, this medication improves blood sugar control in patients with type 2 diabetes.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow whole without chewing with at least 1/2 cup of water. Administer this medicine orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration In patients who have not previously received medication, initiate treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider concomitant use with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the requirement for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, follow the method described under Initial dose. That is, initiate treatment at 1 mg daily and adjust the dose at 1 ~ 2 week intervals. Consider the efficacy and duration of action of the previously administered medicine. 4) Dose monitoring While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia is promptly controlled by immediate intake of sugar. Hypoglycemia may recur after treatment with a sulfonylurea despite successful initial management. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical treatment and follow-up and may sometimes require hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure, and should be used when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal. Initiate insulin at a low dose and increase it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If a patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered concomitantly with metformin, and the risk may increase. Appropriate precautions should be taken.

Precautions

This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or those in coma. Patients with allergies to this medication or its components, or to sulfonylureas, should also refrain from its use. Patients with severely impaired liver or kidney function should not use this medication, and transitioning to insulin therapy is recommended. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication. Patients with severe infections, or those undergoing surgery, or with severe trauma, should also be treated with insulin for safety. Patients who experience diarrhea or vomiting affecting food absorption should be cautious as this medication may pose a risk of hypoglycemia. During the first week of starting this medication, the risk of hypoglycemia is high, so blood sugar should be checked frequently. Particularly, elderly patients, those with poor nutritional status or irregular eating patterns, situations where muscle activity and carbohydrate intake are not balanced, and changes in eating patterns require additional caution. Patients who frequently consume alcohol or have impaired kidney and liver function are also at higher risk for hypoglycemia and should be cautious. Patients who have overdosed on this medication or have endocrine diseases such as thyroid, pituitary, or adrenal dysfunction should be aware of hypoglycemia. Additionally, patients taking specific medications like beta-blockers or those with autonomic neuropathy may not exhibit typical hypoglycemic symptoms and should be more watchful. This medication lowers blood sugar, so hypoglycemia may occur. Symptoms of hypoglycemia may include headache, severe hunger, nausea, fatigue, anxiety, confusion, dizziness, drowsiness, and loss of consciousness. Hypoglycemia is usually quickly reversed by consuming foods or drinks containing sugar. Also, during the initial period of taking this medication, visual blurriness may occur, as well as gastrointestinal disturbances like nausea, vomiting, abdominal pain, and diarrhea. Liver dysfunction, blood abnormalities, and allergic reactions may also occur rarely, so any unusual symptoms should be discussed with a doctor immediately. This medication should be taken regularly, and optimal blood sugar control can only be achieved by combining it with dietary and exercise therapy. Because of the risk of hypoglycemia, always carry sugars and consume them immediately if symptoms appear. In special situations such as stress, surgery, or infection, blood sugar control may become more difficult, so consult with a physician to adjust the treatment method. When taken with other medications, they may affect blood sugar control, so inform your doctor or pharmacist of all medications you are taking. Particularly, caution is needed for potential interactions with certain antibiotics, anticoagulants, steroids, and beta-blockers. Women who are pregnant or breastfeeding should not use this medication, and transitioning to insulin therapy is considered safer if needed. Elderly patients may have reduced kidney function, so dosage should be adjusted and used carefully. Overdose may lead to severe hypoglycemia, so visit a medical institution immediately for appropriate treatment. This medication must be stored out of reach of children and should be kept in the original container for safety.

Side effects

Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or drive, depression, confusion, language impairment, aphasia, visual impairment, tremors, incomplete paralysis, sensory abnormalities, dizziness, weakness, loss of self-control, temporary mental confusion, seizures, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorder, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, granulocytopenia, agranulocytosis, pancytopenia, itching, urticaria, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, mucocutaneous syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disorders, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial edema, erectile dysfunction, facial flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is also best to keep the medication at room temperature between 1°C and 30°C. Avoid places that are too hot or too cold, and keep it in a cool place away from direct sunlight.

Appearance and packaging

Appearance

Green rectangular tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.